Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
Korrapati V. Sathyasaikumar, Verónica Pérez de la Cruz, Benjamín Pineda, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 18

Showing 18 citing articles:

Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
The role of the kynurenine pathway in cardiovascular disease
Yuehang Yang, Xing Liu, Xinyi Liu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 15
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 9
An integrated cytokine and kynurenine network as the basis of neuroimmune communication
Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Trevor W. Stone, L. Gail Darlington, Abdulla A.‐B. Badawy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9040-9040
Open Access | Times Cited: 4
Mechanisms of acupuncture in treating depression: a review
MA Jian-fu, Xuan Yin, Kaiyu Cui, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Xanthurenic acid: A role in brain intercellular signaling
Michel Maître, Omar Taleb, Hélène Jeltsch‐David, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 9, pp. 2303-2315
Open Access | Times Cited: 3
Role of Kynurenine and Its Derivatives in the Neuroimmune System
Makoto Fujikawa, Masashi Ueda, Kenta Maruyama
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7144-7144
Open Access | Times Cited: 3
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment
Paul Carrillo‐Mora, Carlos Landa‐Solís, David Valle‐García, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 983-983
Open Access | Times Cited: 2
Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies
Yashika Bansal, Raghunath Singh, Rupinder Kaur Sodhi, et al.
Neuropharmacology (2022) Vol. 215, pp. 109169-109169
Closed Access | Times Cited: 10
Huntingtin Interacting Proteins and Pathological Implications
Li Liu, Huichun Tong, Yize Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13060-13060
Open Access | Times Cited: 6
The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy
Yu Wang, Xinyu Fang, Guangfa Wang, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 1-11
Closed Access | Times Cited: 4
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline
Masaya Hasegawa, Kazuo Kunisawa, Bolati Wulaer, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies against Obesity and Depression Symptoms
Tiffany Y. Wences Chirino, Edgar Rangel‐López, Alexandra Luna‐Angulo, et al.
(2023)
Open Access | Times Cited: 2
Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine
Hisayoshi Kubota, Kazuo Kunisawa, Moe Niijima, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 629, pp. 142-151
Open Access | Times Cited: 4
Ameliorative effect of diclofenac in rotenone corneal kindling model of drug-resistant epilepsy: Edge of dual COX and KMO inhibition
Samriti, Arvinder Kaur, Arshbir Kaur, et al.
Brain Research (2024), pp. 149246-149246
Closed Access
Recent Advances in the Study of Huntingtin Interacting Proteins
Shihua Li, Huichun Tong, Gongke Zhou, et al.
(2023)
Open Access | Times Cited: 1
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms
Tiffany Y. Wences Chirino, Edgar Rangel‐López, Alexandra Luna Angulo, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1421-1421
Open Access | Times Cited: 1
Page 1

Scroll to top